Phase
Condition
Memory Loss
Neurologic Disorders
Multiple Sclerosis
Treatment
N/AClinical Study ID
Ages 18-65 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- All patients approved for treatment with aHSCT in the Netherlands in accordance withthe Dutch criteria for aHSCT treatment for RRMS
Exclusion
Exclusion Criteria:
Contra-indications for treatment with aHSCT such as known hypersensitivity to themedication used for aHSCT
Clinically relevant comorbidities preventing safe use of medication used for aHSCT
Severe clinical depression
Active addiction to drugs or alcohol
Active infections such as but not limited to tuberculosis, cytomegalovirus,Epstein-Barr virus, herpes simplex, varicella zoster, viral hepatitis,toxoplasmosis, HIV or syphilis.
Active malignancy or history of malignancy with the exception of local basal cellcarcinoma or carcinoma in situ of the cervix
Study Design
Connect with a study center
Amsterdam UMC
Amsterdam,
NetherlandsActive - Recruiting
St. Antonius Hospital
Nieuwegein,
NetherlandsActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.